VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
VRTXVertex Pharmaceuticals Incorporated
$451.63$114.9B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksVRTXPrice History

VRTX logoVertex Pharmaceuticals Incorporated (VRTX) Stock Price History

Historical prices from 1991 to 2026

$451.63-7.52  (-1.64%)close Jun 18
Returns
1M
+3.4%
3M
+0.0%
YTD
-0.1%
1Y
+0.7%
3Y
+9.6%
5Y
+19.2%
ATH$519.88Nov 2024-13.1%
ATL$3.25Feb 1993pre-split
Avg Vol (50D)1.1M/ day
52-Week Range$362.50 — $507.92
LowCurrent: $451.63High

Loading 10-year price history...

VRTX Historical Performance

1 YearTotal Return
+0.7%
Price: +0.7%
3 YearsTotal Return
+31.8%
CAGR: +9.6%
Price: +31.8%
5 YearsTotal Return
+140.4%
CAGR: +19.2%
Price: +140.4%
YTD
-0.1%

VRTX Annual Returns

Year-by-year price performance · 2002–2026

Best+280.7%2000
Worst-61.0%2001
Up years17/25
2002-35.4%
2003-36.7%
2004+0.7%
2005+170.2%
2006+34.1%
2007-37.0%
2008+31.2%
2009+39.6%
2010-20.8%
2011-7.7%
2012+30.0%
2013+70.2%
2014+60.9%
2015+2.2%
2016-40.1%
2017+100.1%
2018+8.4%
2019+33.4%
2020+7.7%
2021-4.3%
2022+29.8%
2023+42.3%
2024-2.0%
2025+11.7%
2026+9.9%
2002 annual price return
-35.4%
2003 annual price return
-36.7%
2004 annual price return
+0.7%
2005 annual price return
+170.2%
2006 annual price return
+34.1%
2007 annual price return
-37.0%
2008 annual price return
+31.2%
2009 annual price return
+39.6%
2010 annual price return
-20.8%
2011 annual price return
-7.7%
2012 annual price return
+30.0%
2013 annual price return
+70.2%
2014 annual price return
+60.9%
2015 annual price return
+2.2%
2016 annual price return
-40.1%
2017 annual price return
+100.1%
2018 annual price return
+8.4%
2019 annual price return
+33.4%
2020 annual price return
+7.7%
2021 annual price return
-4.3%
2022 annual price return
+29.8%
2023 annual price return
+42.3%
2024 annual price return
-2.0%
2025 annual price return
+11.7%
2026 annual price return
+9.9%
LessMore
Alpha vs S&P 500
1Y-24.3%
3Y-9.3%
5Y+7.0%

Price returns only.

Download Historical Data

8,790 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

VRTX Stock Price Trajectory (1991–2026)

As of June 21, 2026, Vertex Pharmaceuticals Incorporated (VRTX) trades at $451.63, representing a +0.7% return over the past year. The stock has delivered a +140.4% total return over five years (+19.2% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $519.88 on November 8, 2024. From this peak, VRTX has corrected -13.1%, currently trading 3% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers REGN (+18.8% 1Y), ALNY (-11.0% 1Y), and BMRN (-1.0% 1Y), VRTX has underperformed the peer group average. Compare VRTX vs REGN →

VRTX Historical Price Data · from 1991

Rows 1–50 of 8,790
Date Open High Low Close Volume Change %
2026-06-18462.49464.98450.39451.632.67M-1.64%
2026-06-17449.67464.31447.54459.151.41M+1.32%
2026-06-16451.25454.52444.21453.171.15M+0.55%
2026-06-15444.93453.68444.93450.691.48M+1.30%
2026-06-12440.02447.70440.02444.93919K-0.03%
2026-06-11437.51445.78435.21445.041.23M+2.14%
2026-06-10446.18447.50433.80435.71949K-2.26%
2026-06-09447.02449.50440.90445.77871K+0.63%
2026-06-08443.17448.69441.72442.96988K-0.87%
2026-06-05445.70453.15443.91446.831.53M+1.15%
2026-06-04434.95448.19433.50441.751.32M+3.11%
2026-06-03420.01429.01420.01428.411.32M+0.78%
2026-06-02431.65434.00424.90425.091.08M-3.04%
2026-06-01441.00443.54433.26438.401.11M-2.04%
2026-05-29448.00450.00442.25447.541.41M-0.10%
2026-05-28434.08449.29434.08447.971.15M+2.46%
2026-05-27437.85445.35435.39437.221.09M+0.30%
2026-05-26437.99441.99433.93435.93865K+0.32%
2026-05-22437.07437.07434.52434.521.71M+0.23%
2026-05-21429.36434.74426.01433.541.30M+0.72%
2026-05-20434.31439.39427.64430.461.68M-0.89%
2026-05-19435.68444.32433.15434.311.15M-0.52%
2026-05-18435.42440.04430.25436.581.40M-0.03%
2026-05-15452.43453.45435.86436.731.24M-3.04%
2026-05-14453.64456.68447.45450.41966K-0.62%
2026-05-13446.47455.32444.26453.211.12M+1.10%
2026-05-12439.23454.23436.50448.291.37M+3.01%
2026-05-11432.30442.15428.50435.171.16M+1.24%
2026-05-08422.37431.94421.17429.85953K+1.14%
2026-05-07425.13429.51423.59425.00932K-0.62%
2026-05-06423.09430.63422.91427.651.11M+0.78%
2026-05-05433.92433.94412.27424.36585K-1.28%
2026-05-04423.73430.13422.11429.851.37M+1.40%
2026-05-01425.02427.38421.54423.92778K-0.81%
2026-04-30424.26430.95423.65427.381.12M+0.98%
2026-04-29424.44426.72419.71423.241.06M-1.60%
2026-04-28430.40431.77426.68430.14807K+0.97%
2026-04-27428.23434.07425.87426.01966K-1.04%
2026-04-24431.93433.68427.38430.501.12M-1.06%
2026-04-23440.71442.04433.81435.10776K-0.59%
2026-04-22437.38441.00435.45437.67695K+0.25%
2026-04-21437.12440.32429.65436.59951K-0.59%
2026-04-20441.11442.15437.67439.18705K-0.46%
2026-04-17441.55443.90437.58441.20946K+1.27%
2026-04-16442.35445.93431.15435.651.33M-1.36%
2026-04-15447.82447.82437.19441.651.35M-0.59%
2026-04-14441.11444.76435.28444.281.43M+0.96%
2026-04-13434.13445.06433.68440.05937K+0.87%
2026-04-10446.13446.75434.25436.27932K-2.34%
2026-04-09440.68447.00436.35446.74959K+0.64%
…
Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into VRTX consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

VRTX — Frequently Asked Questions

Quick answers to the most common questions about buying VRTX stock.

How has VRTX stock performed recently?

VRTX returned +0.7% over the past year, beating its 5-year annualized CAGR of +19.2%. The stock trades above its 200-day moving average, confirming the uptrend.

What is VRTX's all-time high price?

Vertex Pharmaceuticals Incorporated reached $519.88 on 2024-11-08. The 52-week high is $507.92. Current 1-year return of +0.7% places the stock closer to historical peaks.

Where can I download VRTX historical price data?

This page provides VRTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 1991-2026, downloadable in CSV format.

490 data points · sampled from 8,790